Work

Response Rates and Outcomes with Enzalutamide for Patients with Metastatic Castration Resistant Prostate Cancer and Visceral Disease in the Prevail Trial

Year: 2014

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu336.15

Authors: C. Higano, J. Alumkal, S. Chowdhury, Y. Loriot, C.N. Sternberg, J.S. de Bono, B. Tombal, J. Carles, F.G. Perabo, D. Forer, S. Noonberg, H. Mansbach, T. Beer

Institutions: Seattle Cancer Care Alliance, University of Washington, OHSU Knight Cancer Institute, Guy's Hospital, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, Institut Gustave Roussy, Azienda Ospedaliera San Camillo-Forlanini, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Cliniques Universitaires Saint-Luc, Vall d'Hebron Hospital Universitari, Astellas Pharma (United States), Medivation, Inc. (United States), Oregon Health & Science University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2188431798

FWCI: 1.215

Cites:

Cited by: 5

Related to: 10